| Small GTPases: Structure, biological function and its interaction with nanoparticles S Song, W Cong, S Zhou, Y Shi, W Dai, H Zhang, X Wang, B He, Q Zhang Asian journal of pharmaceutical sciences 14 (1), 30-39, 2019 | 64 | 2019 |
| Thiolated nanoparticles overcome the mucus barrier and epithelial barrier for oral delivery of insulin S Zhou, H Deng, Y Zhang, P Wu, B He, W Dai, H Zhang, Q Zhang, R Zhao, ... Molecular Pharmaceutics 17 (1), 239-250, 2019 | 25 | 2019 |
| The function and mechanism of preactivated thiomers in triggering epithelial tight junctions opening Y Zhang, S Zhou, F Deng, X Chen, X Wang, Y Wang, H Zhang, W Dai, ... European Journal of Pharmaceutics and Biopharmaceutics 133, 188-199, 2018 | 25 | 2018 |
| Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines X Liu, Y Zhang, S Zhou, L Dain, L Mei, G Zhu Journal of Controlled Release 348, 84-94, 2022 | 22 | 2022 |
| pH‐Responsive STING‐Activating DNA Nanovaccines for Cancer Immunotherapy Y Zhang, T Shen, S Zhou, W Wang, S Lin, G Zhu Advanced therapeutics 3 (9), 2000083, 2020 | 18 | 2020 |
| Delivery of nucleic acid therapeutics for cancer immunotherapy S Zhou, W Chen, J Cole, G Zhu Medicine in drug discovery 6, 100023, 2020 | 18 | 2020 |
| Nucleic acid immunotherapeutics for cancer T Shen, Y Zhang, S Zhou, S Lin, XB Zhang, G Zhu ACS applied bio materials 3 (5), 2838-2849, 2020 | 12 | 2020 |
| Responsive multivesicular polymeric nanovaccines that codeliver STING agonists and neoantigens for combination tumor immunotherapy T Su, F Cheng, J Qi, Y Zhang, S Zhou, L Mei, S Fu, F Zhang, S Lin, G Zhu Advanced science 9 (23), 2201895, 2022 | 10 | 2022 |
| ExoHCR: a sensitive assay to profile PD-L1 level on tumor exosomes for immunotherapeutic prognosis L Hu, W Chen, S Zhou, G Zhu Biophysics reports 6, 290-298, 2020 | 2 | 2020 |
| STING pathway and modulation for cancer immunotherapy T Su, NT Ahmed, S Zhou, X Liu, G Zhu Cancer Immunology and Immunotherapy, 353-373, 2022 | | 2022 |
